Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Burcon NutraScienceBRCNF 32 Debt-to-Equity is -4.21 as of Mar. 2026. GuruFocus rates BRCNF with a GF Score™ of 32/100 and a GF Value™ of $7.65 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,747 Consumer Packaged Goods companies, Burcon NutraScience ranks worse than 57240.93% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Burcon NutraScience's Debt-to-Equity or its related term are showing as below:
BRCNF'
s Debt-to-Equity Range Over the Past 10 Years
Min: -4.21 Med: 0.37 Max: 3.23
Current: -4.21
During the past 13 years, the highest Debt-to-Equity Ratio of Burcon NutraScience was 3.23. The lowest was -4.21. And the median was 0.37.
BRCNF's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.41
vs BRCNF: -4.21
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Burcon NutraScience Debt-to-Equity Related Terms
Burcon NutraScience Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Burcon NutraScience's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Burcon NutraScience's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burcon NutraScience Debt-to-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Burcon NutraScience's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Burcon NutraScience's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Burcon NutraScience (BRCNF) has a Debt-to-Equity of -4.21 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Burcon NutraScience and its competitors. According to the industry distribution chart, Burcon NutraScience ranks #999999 out of 1747 companies in the Consumer Packaged Goods industry.
Is Burcon NutraScience's Debt-to-Equity too high?
Burcon NutraScience's current Debt-to-Equity is -4.21. Based on the distribution chart, Burcon NutraScience ranks #999999 out of 1747 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Burcon NutraScience has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Burcon NutraScience's Debt-to-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Burcon NutraScience ranks #999999 out of 1747 companies for Debt-to-Equity. This places Burcon NutraScience in the lower half of its industry. The industry median Debt-to-Equity is 0.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.41, based on 1,747 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Burcon NutraScience and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burcon NutraScience's current Debt-to-Equity is -4.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burcon NutraScience stock overvalued right now?
Based on GuruFocus' analysis, Burcon NutraScience (BRCNF) is currently considered Possible Value Trap. The stock's GF Value™ is $7.65, compared to a current price of $1.34 — trading 82.5% below its estimated fair value. The current Debt-to-Equity is -4.21. Burcon NutraScience's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Burcon NutraScience (BRCNF), the current Debt-to-Equity is -4.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burcon NutraScience (BRCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Burcon NutraScience stock appears to be undervalued.
The current stock price of $1.34 is trading 82.5% below its estimated GF Value™ of $7.65.
GuruFocus considers Burcon NutraScience to be Possible Value Trap.
Key valuation signals for BRCNF:
Debt-to-Equity: -4.21
GF Value™: $7.65 vs. price of $1.34 (82.5% below fair value)
No single metric tells the full story. See the BRCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burcon NutraScience Corp is a technology company in the development of plant-based proteins. With several issued patent applications, that have been developed, Burcon has grown a portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed, and more. Its joint venture Merit Foods is building a protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.
32GF Score
Get the complete analysis for BRCNF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRCNF has been successfully added to your 
